Briefing.com

Upgrades/Downgrades

Updated: 28-Aug-26 12:05 ET

Upgrades
Company Ticker Brokerage Firm Ratings Change Price Target
Chagee CHA Macquarie Neutral » Outperform
Moderna MRNA Argus Hold » Buy $180
Evolution Petroleum EPM Northland Capital Market Perform » Outperform $4
Enbridge ENB CIBC Neutral » Sector Outperform
Baozun BZUN CLSA Hold » Outperform $3.80
Downgrades
Company Ticker Brokerage Firm Ratings Change Price Target
FinVolution Group FINV Citigroup Buy » Neutral $4.10
Workday WDAY CapitalOne Overweight » Equal Weight $219
VTEX VTEX Morgan Stanley Overweight » Equal-Weight $4
Allstate ALL Argus Buy » Hold
Coverage Initiated
Company Ticker Brokerage Firm Ratings Change Price Target
Octave Specialty Group (Ambac) OSG Keefe Bruyette Outperform $8
The Metals Company TMC Stifel Buy $10
TeraWulf WULF William Blair Outperform
Rhythm Pharmaceuticals RYTM Deutsche Bank Hold $120
The Metals Royalty Company TMCR Stifel Buy $10
Coverage Resumed
Company Ticker Brokerage Firm Ratings Change Price Target
UMB Financial Corporation UMBF Raymond James Outperform $165
CapsoVision CV Roth Capital Buy $9
Coverage Reiterated/Price Tgt Changed*
Company Ticker Brokerage Firm Ratings Change Price Target
Build-A-Bear Workshop BBW DA Davidson Buy $60 » $37
Amazon AMZN Evercore ISI Outperform $315 » $355
Rubrik RBRK BMO Capital Markets Outperform $98 » $115
Autodesk ADSK BMO Capital Markets Market Perform $262 » $283
Workday WDAY BMO Capital Markets Outperform $182 » $230
Five Below FIVE Telsey Advisory Group Outperform $260 » $280
Dollar General DG Telsey Advisory Group Market Perform $125 » $140
RingCentral RNG Needham Buy $55 » $85
Affirm AFRM Oppenheimer Outperform $100 » $104
Marvell MRVL Oppenheimer Outperform $300 » $325
Workday WDAY Monness Crespi & Hardt Buy $202 » $218
(a) Brokerage firm initiating coverage participated in underwriting the recent IPO.
(b) Brokerage firm resumes coverage.
(c) Brokerage firm participated in the secondary offering.
* This list of reiterations/target changes is not comprehensive.

Copyright © Briefing.com. All rights reserved.